Ironwood (IRWD) Director Alexander Denner Receives 3,694-Share Award

What Happened

Alexander J. Denner, a director of Ironwood Pharmaceuticals, received an award of 3,694 shares on September 15, 2026. The shares were issued at $0.00 (no cash paid) under the grant/award code (A), resulting in $0 reported acquisition value of $0. This is a director compensation grant, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-15; Form 4 filed: 2026-09-17 (timely filing).
• Instrument: Award/Grant (code A); Shares granted: 3,694; Price per share reported: $0.00; Total reported value: $0.
• Shares owned after transaction: Not specified in the filing.
• Footnote: Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024.
• Filing status: No late filing indicated.

Context

Director equity awards are routine compensation meant to align directors with shareholder interests and do not by themselves indicate personal bullish or bearish trading. Because this was an award (not a purchase or sale), it reflects standard non-employee director pay rather than a market-timed trade.